Mo W - Search Results

1

Breast carcinoma associated with prolactinoma: A case report.

Zheng Y, Mo W, Yu Y, Zou D, He X, Xia X, Hu J. Zheng Y, et al. Among authors: mo w. Cancer Biol Ther. 2017 Mar 4;18(3):132-136. doi: 10.1080/15384047.2017.1294284. Epub 2017 Feb 17. Cancer Biol Ther. 2017. PMID: 28278079 Free PMC article.

2

Serum tissue polypeptide-specific antigen is an independent predictor in breast cancer.

Xie S, Ding X, Mo W, Chen J. Xie S, et al. Among authors: mo w. Acta Histochem. 2014 Mar;116(2):372-6. doi: 10.1016/j.acthis.2013.09.001. Epub 2013 Oct 18. Acta Histochem. 2014. PMID: 24144486

3

INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts.

Yu Y, Huang R, Zong X, He X, Mo W. Yu Y, et al. Among authors: mo w. BMC Cancer. 2016 Jul 7;16:397. doi: 10.1186/s12885-016-2473-0. BMC Cancer. 2016. PMID: 27389040 Free PMC article.

4

Long non-coding RNAs may serve as biomarkers in breast cancer combined with primary lung cancer.

Ding X, Zhang Y, Yang H, Mao W, Chen B, Yang S, Ding X, Zou D, Mo W, He X, Zhang X. Ding X, et al. Among authors: mo w. Oncotarget. 2017 Apr 21;8(35):58210-58221. doi: 10.18632/oncotarget.17356. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938549 Free PMC article.

5

Associations between folate metabolism enzyme polymorphisms and breast cancer: A meta-analysis.

Mo W, Ding Y, Zheng Y, Zou D, Ding X. Mo W, et al. Breast J. 2020 Mar;26(3):484-487. doi: 10.1111/tbj.13527. Epub 2019 Sep 23. Breast J. 2020. PMID: 31549463

6

Prognosis and endocrine therapy selection for patients with low hormone receptor-positive breast cancer following neoadjuvant chemotherapy: A retrospective study of 570 patients in China.

Ding Y, Ding K, Yu K, Zou D, Yang H, He X, Mo W, Yu X, Ding X. Ding Y, et al. Among authors: mo w. Oncol Lett. 2019 Dec;18(6):6690-6696. doi: 10.3892/ol.2019.11033. Epub 2019 Nov 1. Oncol Lett. 2019. PMID: 31807179 Free PMC article.

7

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.

Ding Y, Ding K, Qian H, Yu X, Zou D, Yang H, Mo W, He X, Zhang F, Qin C, Zheng Y, Ding X. Ding Y, et al. Among authors: mo w. PLoS One. 2020 Apr 16;15(4):e0231895. doi: 10.1371/journal.pone.0231895. eCollection 2020. PLoS One. 2020. PMID: 32298374 Free PMC article.

8

The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience.

Zheng Y, Ding X, Zou D, Zhang F, Qin C, Yang H, Mo W, Ding Y, Yu Y. Zheng Y, et al. Among authors: mo w. Cancer Biol Ther. 2020 Aug 2;21(8):675-687. doi: 10.1080/15384047.2020.1756707. Epub 2020 May 18. Cancer Biol Ther. 2020. PMID: 32420815 Free PMC article.

9

Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients.

Ding Y, Ding K, Yang H, He X, Mo W, Ding X. Ding Y, et al. Among authors: mo w. PLoS One. 2020 May 29;15(5):e0234058. doi: 10.1371/journal.pone.0234058. eCollection 2020. PLoS One. 2020. PMID: 32470093 Free PMC article.

10

Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.

Mo W, Ding Y, Zhao S, Zou D, Ding X. Mo W, et al. PLoS One. 2020 Nov 10;15(11):e0241924. doi: 10.1371/journal.pone.0241924. eCollection 2020. PLoS One. 2020. PMID: 33170908 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,017 results

Search Page

Filters